Pliant Therapeutics, Inc. · NASDAQ:PLRX
Point72 Asset Management, L.P.'s stake in Pliant Therapeutics, Inc. fell to 0.10% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Point72 Asset Management, L.P.'s stake in Pliant Therapeutics, Inc. fell to 0.10%, 46,537 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 0.10%
- Shares
- 46,537
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 0.10% | 46,537 |
| Point72 Capital Advisors, Inc. | 0.10% | 46,537 |
| Steven A. Cohen | 0.10% | 46,537 |
Source
Related
- Pliant Therapeutics, Inc.
- Point72 Asset Management, L.P.
- Pliant Therapeutics, Inc. shareholders
- Schedule 13G · Point72 Asset Management, L.P. · Sep 4, 2025
- Schedule 13G/A · Citadel Advisors LLC · Aug 14, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Woodline Partners LP · Feb 17, 2026
- Schedule 13G · Citadel Advisors LLC · Feb 9, 2026
- Schedule 13G · Citadel Advisors LLC · Jan 30, 2026